Transvaginal Ultrasound best Detector of dangerous Ectopic Pregnancies

These scans examine a woman’s reproductive organs, including the uterus, ovaries, cervix and vagina

Women with symptoms in early pregnancy shouldn't rely on clinical exam alone, experts say
Ultrasound best Detector of Dangerous Ectopic Pregnancies

Ectopic pregnancy, in which the fertilized egg grows in the fallopian tubes or other spots outside the uterus, typically leads to miscarriage and can even prove fatal.  Now, a review of the data finds that taking a patient’s history along with a clinical exam is not enough to diagnose the condition in women with abdominal pain or vaginal bleeding during early pregnancy.
Instead, the researchers concluded that transvaginal ultrasound is the single best way to evaluate suspected ectopic pregnancy. These scans examine a woman’s reproductive organs, including the uterus, ovaries, cervix and vagina
. ”
DES Daughters are at a higher risk for ectopic/tubal pregnancies.

Read Women with symptoms in early pregnancy shouldn’t rely on clinical exam alone, experts say by Robert Preidt, April 23, 2013
Sources Does This Woman Have an Ectopic Pregnancy? The Rational Clinical Examination Systematic Review by the JAMA Network

US Judge removes BPA from California State’s list of Toxics two Weeks after it had been added!

The chemical industry called the preliminary injunction a minor victory

Judge removes BPA from list of toxics
Companies making BPA and the FDA, claim that the substance is safe if used sensibly. But others aren’t so sure.

Two weeks ago, California had become the latest state to place restrictions on the chemical known as Bisphenol-A,  a controversial chemical used in plastics and metal food containers, and declare it a reproductive toxicant – ref post California decides chemical BPA is toxic. However, as part of a lawsuit against a California agency, a judge ordered Friday April 19, 2013 that BPA  be removed from the state’s list of reproductive toxicants.

Read Judge removes BPA from list of toxics by Stephanie M. Lee

Related posts:

Deux Filles Distilbène en Cour d’Appel

Verdicts variables pour les deux plaignantes – 3

Marie-Elise Pesenti a développé un cancer de l’utérus diagnostiqué à l’âge de 21 ans. Un adénocarcinome à cellules claires, typique des effets du Distilbène®. Dix-sept ans de combats – Une lutte inégale – Une bataille sans fin ?  (Marie-Elise vidéo3)

Revues de presse

Le Distilbène DES, en savoir plus

Good read on Breast Cancer Mechanism and Treatment Alternatives

Cancer-Free, your guide to Non-toxic Healing Of Cancer
by Bill Henderson

Cancer-Free, your guide to Non-toxic Healing Of Cancer
Recommended Reading : Cancer-Free by Bill Henderson

Breast cancer is the cancer initiating from breast tissue, most usually from the internal lining of milk channels or the lobules that brings milk to the duct. Cancers instigating from ducts are identified as ductal carcinomas; those instigating from lobules are identified as lobular carcinomas. Breast cancer is the most general cause of cancer in women. Whilst the mainstream of novel breast cancers are diagnosed on account of an aberration seen on a mammogram, a bump or alter in uniformity of the breast tissue can also be a caveat symbol of the ailment. ”

Read Breast Cancer by Avinash Kabra, May 9, 2010
The book Cancer-Free, your guide to Non-toxic Healing Of Cancer
by Bill Henderson

All our posts on Breast Cancer – CancerWomen’s Health

Women with sufficient Amounts of Vitamin D 32% less likely to develop Uterine Fibroids

Vitamin D may reduce risk of uterine fibroids, according to NIH study

Vitamin D may reduce risk of uterine fibroids, according to NIH study
Vitamin D sources

Fibroids, also known as uterine leiomyomata, are noncancerous tumors of the uterus. Fibroids often result in pain and bleeding in premenopausal women, and are the leading cause of hysterectomy in the United States.

DES Action USA commented: ” info for DES Daughters since DES is associated with an increased risk for uterine fibroids “.

Read Vitamin D may reduce risk of uterine fibroids, according to NIH study by Robin Mackar, NIEHS, April 15, 2013

Deux Filles Distilbène en Cour d’Appel

Verdicts variables pour les deux plaignantes – 2

Marie-Elise Pesenti a développé un cancer de l’utérus diagnostiqué à l’âge de 21 ans. Un adénocarcinome à cellules claires, typique des effets du Distilbène®. Problème : l’ordonnance prescrite à sa mère a disparu. Ce qui explique le long combat judiciaire menée par sa fille depuis 2003. – (Marie-Elise vidéo2)

Revues de presse

Le Distilbène DES, en savoir plus

Prescription Drugs responsible for more Deaths than traffic Accidents

Every 14 minutes, a person is killed by prescription drugs…

Prescription drugs responsible for more deaths than traffic accidents, study finds
The number of drug fatalities has doubled within the past ten years

Every 14 minutes, a person is killed by prescription drugs — and unlike most other causes of preventable death, which have been on the decline for years, medication-induced deaths are on the upswing across the US. According to a recent analysis conducted by the Los Angeles Times, drug-induced deaths have become so prevalent that their average yearly total now exceeds the number of deaths caused by traffic accidents “.

Read Prescription Drugs responsible for more Deaths than traffic Accidents, Study finds, by Ethan A. Huff, September 21, 2011

BPA Regulations: the FDA stating that Bisphenol A Exposure listed on today’s Packaging is “safe”

Bisphenol A (BPA): Use in Food Contact Application

FDA declares BPA exposure is safe! Don't worry about gender-bender chemicals
The FDA now states that BPA is “safe” at the exposure level listed on current product packaging

Despite countless scientific evidence explaining the dangers of Bisphenol-A (BPA), the Food and Drug Administration (FDA) refuses to ban this highly profitable industrial chemical.
In their “current perspective on BPA the FDA now states that the chemical is safe at the exposure level listed on current product packaging.

In her post FDA declares BPA exposure is safe! Don’t worry about gender-bender chemicals, Lance Devon covers:

  • BPA – wreaking havoc on hormones
  • Infertility and hysterectomy on the rise
  • FDA’s wobbly stance on BPA cannot be trusted
  • Fish are losing their gender and species identity
  • Stop BPA before it depopulates the planet

Une Fille Distilbène en Cour d’Appel

Long combat judiciaire menée par Marie-Elise depuis 2003

Marie-Elise Pesenti a développé un cancer de l’utérus diagnostiqué à l’âge de 21 ans. Un adénocarcinome à cellules claires, typique des effets du Distilbène®. Problème : l’ordonnance prescrite à sa mère a disparu. Ce qui explique le long combat judiciaire menée par sa fille depuis 2003.  – (Marie-Elise vidéo1)

Revues de presse

Le Distilbène DES, en savoir plus

Why don’t we test drugs on pregnant women and children? To protect them from untested Drugs…

It’s the Catch-22 of clinical trials…

"Why don't we test drugs on women and children? To protect them from untested Drugs"
Watch @DES_Journal diaporama and health cartoon album on Flickr.
Image via @hildabast

It’s the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs….we don’t test drugs adequately for them. In the last few decades, we’ve been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for “vulnerable populations,” like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. “

  • Read Statistically funny, commenting on the science of unbiased health research with cartoons.
  • All our related posts about the #AllTrials campaign.

On Flickr®

Watch @DES_Journal diaporama and health cartoons album on  DES Diethylstilbestrol's photostream on Flickr

If you already have a flickr® account, add us as a contact
Email your photos to des.daughter@gmail.com with a short description and title :-)